Skip to content
Search

Latest Stories

Northern Ireland releases plan to fully realise the potential of community pharmacies

Northern Ireland releases plan to fully realise the potential of community pharmacies

NI Community Pharmacy Strategic Plan 2030 envisions an expansion of clinical services offered by community pharmacies

The Department of Health (DoH) in Northern Ireland has published a new Strategic Plan for Community Pharmacy, highlighting the vision and key priorities for the sector over the next 10 years.


Co-developed by the DoH and Community Pharmacy Northern Ireland (CPNI), the representative body for community pharmacy owners, the plan aims to fully realise the potential of community pharmacy services to support better health outcomes from medicines and prevent illness.

The vision outlined in the plan sees community pharmacies offering more clinical services, leveraging the skills of their teams to provide the public with safe, convenient, and faster access to care.

According to DOH, the vision will be realised through four major reform programmes focusing on services, legislation, workforce, and digital enablers, alongside six strategic priorities.

Together, these initiatives are anticipated to transform the role of community pharmacy within the Health and Social Care (HSC).

Health Minister Robin Swann has extended his support to the new Community Pharmacy Strategic Plan, which builds on the previously agreed 3-year community pharmacy commissioning plan.

Swann recognised that while additional investment has been allocated to the community pharmacy sector, further funding will be required to “fully deliver” this Strategic Plan up to 2030.

“I am very conscious that the Community Pharmacy sector – like all sectors across health and social care – is keen to see further investment,” he said.

Professor Cathy Harrison, Chief Pharmaceutical Officer for Northern Ireland, hailed the Community Pharmacy Strategic Plan stating that it “describes a positive and ambitious vision for community pharmacy in Northern Ireland.”

“It outlines how the delivery of planned reforms in the period up to 2030 will provide the public with continued access to medicines from pharmacies plus an increased range of clinical services.”

“This will help realise the potential within community pharmacy teams to provide quicker access to care for acute and long-term conditions in local communities, utilising advances in medicines, diagnostics, digital and medical technologies,” she added.

The key priorities for the next decade include:

  1. Expanding clinical services at community pharmacies to enhance patient care
  2. Modernising systems to ensure safe and reliable medicine supply and professional advice at community pharmacies
  3. Enhancing the skills and capacity of the community pharmacy workforce
  4. Building digital architecture to ensure safe, efficient, paperless systems
  5. Strengthening community links to tackle health inequalities and improve health literacy
  6. Promoting community pharmacy as a great place or training, work, and building pharmacy careers.

The plan will be implemented in a phased approach over the coming years by collaborating with Community Pharmacy NI and the pharmacy profession, the DOH said.

Commenting on the release of NI’s Community Pharmacy Strategic Plan, Professor Harry McQuillan, Chairman of Numark, said: “It is particularly pleasing to see a vision specific to the community pharmacy sector with a bold and forward-looking approach to practice to develop patient-centred services, incorporate independent prescribing, advanced practice and support the population health needs.”

Numark members comprise a large number of community pharmacies in Northern Ireland and across the UK.

Professor McQuillan noted that Numark will be working to fully support its members to realise the vision and assist in delivering the stated six strategic priorities.

“I look forward to working with all stakeholders over the coming years to bring the intended population health and community pharmacy benefits to fruition,” he added.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less